MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Reduces Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. reduced its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 9.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 115,050 shares of the company's stock after selling 11,387 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned about 0.10% of Privia Health Group worth $2,249,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. First Horizon Advisors Inc. lifted its stake in shares of Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after buying an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after buying an additional 2,350 shares in the last quarter. Quadrant Capital Group LLC lifted its stake in shares of Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock valued at $95,000 after buying an additional 511 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in shares of Privia Health Group by 185.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company's stock valued at $98,000 after buying an additional 3,249 shares in the last quarter. Finally, KBC Group NV lifted its stake in Privia Health Group by 48.1% in the 4th quarter. KBC Group NV now owns 5,012 shares of the company's stock worth $98,000 after purchasing an additional 1,627 shares in the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $23.80 on Thursday. The company's fifty day moving average price is $23.41 and its 200-day moving average price is $22.63. The firm has a market capitalization of $2.90 billion, a price-to-earnings ratio of 238.02, a PEG ratio of 3.47 and a beta of 0.87. Privia Health Group, Inc. has a one year low of $16.00 and a one year high of $26.09.

Insider Transactions at Privia Health Group

In related news, CEO Parth Mehrotra sold 13,773 shares of the stock in a transaction on Monday, May 12th. The shares were sold at an average price of $24.99, for a total transaction of $344,187.27. Following the transaction, the chief executive officer now owns 423,143 shares of the company's stock, valued at approximately $10,574,343.57. This trade represents a 3.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO David Mountcastle sold 5,630 shares of the stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total transaction of $125,999.40. Following the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at approximately $4,021,148.88. This represents a 3.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 51,579 shares of company stock valued at $1,226,367 in the last quarter. Insiders own 10.70% of the company's stock.

Analyst Ratings Changes

Several analysts have issued reports on PRVA shares. Piper Sandler increased their target price on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, February 28th. Robert W. Baird increased their target price on shares of Privia Health Group from $24.00 to $26.00 and gave the stock an "outperform" rating in a research note on Tuesday, April 15th. JMP Securities reiterated a "market outperform" rating and issued a $29.00 target price on shares of Privia Health Group in a research note on Monday, April 28th. Needham & Company LLC reiterated a "buy" rating and issued a $30.00 target price on shares of Privia Health Group in a research note on Thursday, April 10th. Finally, Canaccord Genuity Group increased their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Privia Health Group currently has an average rating of "Buy" and an average price target of $27.38.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.